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GenotypingA B S T R A C T
Objective/background: Increasing resistance to various first-line and second-line drugs has
become a major concern in India. However, it is not known if some genotypes are more
associated with second-line drug resistance. Thus, the main aim of this study was to find
out the predominant genotype associated with second-line drug resistance.
Methods: During the study, a total of 234 multidrug resistant (MDR) strains ofMycobacterium
tuberculosis, isolated between 2008 and 2015, were randomly selected and screened for pre-
extensively drug-resistant (XDR) and XDR patterns using second-drug susceptibility testing
with BACTEC MGIT 960. All the MDR isolates were tested against ofloxacin (2 lg/mL), kana-
mycin (2.5 lg/mL), amikacin (1 lg/mL), and capreomycin (2.5 lg/mL). Based on the resis-
tance pattern pre-XDR was defined as M. tuberculosis isolates resistant to fluoroquinolone
alone. The identified pre-XDR and XDR isolates were further characterized using spoligo-
typing. The spoligo patterns obtained were compared and analyzed using SITVIT_WEB
Unweighted Pair Group Method with Arithmetic Mean, and Minimum Spanning Tree was
derived using MIRU-VNTRplus.
Results: Among the 234 MDR strains ofM. tuberculosis, 85 (36.3%) were detected as pre-XDRs
and 15 (6.4%) as XDRs. All the pre-XDR strains were ofloxacin resistant, whereas among the
XDRstrains, 10 (66.6%)were resistant toofloxacin, kanamycin, and capreomycin, four (26.6%)
were resistant to ofloxacin, kanamycin, and amikacin, and one (6.6%) isolatewas resistant to
ofloxacin and kanamycin. Upon spoligotyping analysis, the Beijing lineage was found to be
the single most dominant lineage among the pre-XDR strains (38.8%) followed by CAS
(30.5%), X (7%), T (5.8%), Haarlem (3.5%), EAI (2.3%), and MANU (2.3%). Among the XDR iso-
lates, seven (46.6%) belonged to Beijing, three (20%) belonged to CAS, and one (6.6%) to each
of the EAI, T, URAL, and X lineages. Within the Beijing family, ST1 was the most common in
both pre-XDR (94%) and XDR isolates. All the isolates belonged to the ST1 sublineage.
Conclusion: The Beijing lineage was found to be the single most dominant genotype among
the pre-XDR and XDR isolates.029, India.
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